Tablet Production White Papers & Case Studies

  1. Kemutec Supplies Cone Mills To AstraZeneca 5/28/2007
    Case Study: AstraZeneca
  2. Case Study: AstraZeneca / IBC High Containment Discharge Station With CIP 5/21/2007
    AstraZeneca is one of the worlds leading pharmaceutical companies with a strong portfolio of drugs for treatment of cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory conditions
  3. Fournier Pharma Case Study - Installation of MX5 Microbalance Equipped with MinWeigh 6/16/2006
    The company has to operate in accordance with American standards (each process modification requiring an audit) whereby everything can be traced and everything can be validated, notably in accordance with Food and Drug Administration standards – its three production sites in Chenôve and Fontaine-lès-Dijon in France and Cork in Ireland are all FDA approved...
  4. Case Study: Installation of MX5 Microbalance Equipped with MinWeigh 3/16/2006
    The company has to operate in accordance with American standards (each process modification requiring an audit) whereby everything can be traced and everything can be validated, notably in accordance with Food and Drug Administration standards – its three production sites in Chenôve and Fontaine-lès-Dijon in France and Cork in Ireland are all FDA approved...
  5. Case Study: GlaxoSmithKline South Africa - Quality And Efficiency At The Heart Of New Manufacturing Facility 2/3/2006
    GSK Sth Africa in Cape Town manufactures Albendazole Tablets, which have been remarkably successful in the treatment of LF (Lymphatic Filariasis or Elephantiasis), one of the most disfiguring and disabling tropical diseases
  6. How To Administer Insoluble Active Pharmaceutical Ingredients

    Some active pharmaceutical ingredients are not soluble. In fact, more than 40% of new chemical entities developed in the pharmaceutical industry have little or no solubility in water.

  7. Avoid Product Recalls With Tablet Vision Inspection System

    A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation.

  8. QbD's Role in Pharmaceutical Solid Dose Dry Granulation

    The Pharmaceutical industry is undergoing change. Under fire by political pressures to drive down the cost per tablet, compounded by new drug discovery becoming more challenging escalating research costs, therefore, the industry is looking to unleash its efficiency shackles of the past.

  9. Risk Mitigation In Purchasing Used Pharmaceutical Equipment

    Pharmaceutical manufacturers often rely upon two reasons to justify the purchase of used equipment for their operations: lower prices and faster delivery.

  10. How To Achieve A Dramatic Yield Increase Through The Use Of Anti-Segregation Technologies

    A unique solution improves yields from less than 75% to over 98%.